Status:

COMPLETED

Drug-Food Interaction Study of Seville Orange Juice and Colchicine

Lead Sponsor:

Mutual Pharmaceutical Company, Inc.

Conditions:

Healthy

Eligibility:

All Genders

18-45 years

Phase:

PHASE1

Brief Summary

Seville orange juice is an inhibitor of the intestinal cytochrome P450 (CYP) 3A4 enzyme, one of the enzymes responsible for the metabolism of colchicine. This study will evaluate the effect of multipl...

Detailed Description

Seville orange juice is an inhibitor of the intestinal cytochrome P450 (CYP) 3A4 enzyme, one of the enzymes responsible for the metabolism of colchicine. This study will evaluate the effect of multipl...

Eligibility Criteria

Inclusion

  • Healthy adults 18-45 years of age
  • Non-smoking and non-pregnant (post-menopausal, surgically sterile or using effective contraceptive measures)
  • Body mass index (BMI) greater than or equal to 18 and less than or equal to 32, inclusive
  • Hemoglobin greater than or equal to 11.5g/dL

Exclusion

  • Recent participation (within 28 days) in other research studies
  • Recent significant blood donation or plasma donation
  • Pregnant or lactating
  • Test positive at screening for human immunodeficiency virus (HIV), hepatitis B surface antigen (HbsAg), or hepatitis C virus (HCV)
  • Recent (2-year) history or evidence of alcoholism or drug abuse
  • History or presence of significant cardiovascular, pulmonary, hepatic, gallbladder or biliary tract, renal, hematologic, gastrointestinal, endocrine, immunologic, dermatologic, neurologic, or psychiatric disease
  • Subjects who have used any drugs or substances known to inhibit or induce cytochrome (CYP) P450 enzymes and/or P-glycoprotein (P-gp) within 28 days prior to the first dose and throughout the study
  • Drug allergies to colchicine
  • Intolerance or food allergy to Seville orange juice

Key Trial Info

Start Date :

February 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2009

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT00960193

Start Date

February 1 2009

End Date

April 1 2009

Last Update

June 8 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

PRACS Institute, Ltd. - Cetero Research

Fargo, North Dakota, United States, 58104